Skip to main content

Boston Scientific Ruling Clarifies M&A Termination Rights

Articles | January 29, 2020

Law360 republished a Fried Frank M&A/Private Equity Briefing™ titled, “Court of Chancery Confirms that, Post-Akorn, It Will Evaluate MACs Under the Traditional Framework–Channel v. Boston Scientific.”
 
Click here to read the article (subscription required).

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.